PortfoliosLab logoPortfoliosLab logo
CLNN vs. RLYB
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CLNN vs. RLYB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clene Inc. (CLNN) and Rallybio Corporation (RLYB). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CLNN achieves a -1.87% return, which is significantly lower than RLYB's 192.78% return.


CLNN

1D
-1.87%
1M
-28.80%
YTD
-1.87%
6M
-20.22%
1Y
46.94%
3Y*
-34.82%
5Y*
-51.34%
10Y*

RLYB

1D
-0.99%
1M
13.81%
YTD
192.78%
6M
204.36%
1Y
583.02%
3Y*
-36.91%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

CLNN vs. RLYB - Yearly Performance Comparison


2026 (YTD)20252024202320222021
CLNN
Clene Inc.
-1.87%10.55%-10.49%-70.34%-75.61%-49.32%
RLYB
Rallybio Corporation
192.78%-28.53%-59.83%-63.62%-31.13%-32.34%

Correlation

The correlation between CLNN and RLYB is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.07

Correlation (All Time)
Calculated using the full available price history since Jul 30, 2021

0.12

Fundamentals

Market Cap

CLNN:

$67.07M

RLYB:

$91.42M

EPS

CLNN:

-$3.24

RLYB:

-$1.41

PS Ratio

CLNN:

443.94

RLYB:

103.99

Total Revenue (TTM)

CLNN:

$134.00K

RLYB:

$858.00K

Gross Profit (TTM)

CLNN:

$96.00K

RLYB:

$643.00K

EBITDA (TTM)

CLNN:

-$23.91M

RLYB:

-$32.06M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Clene Inc.

Rallybio Corporation

Often compared with RLYB:
RLYB vs. CNSP

Return for Risk

CLNN vs. RLYB — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLNN
CLNN Risk / Return Rank: 5858
Overall Rank
CLNN Sharpe Ratio Rank: 5656
Sharpe Ratio Rank
CLNN Sortino Ratio Rank: 6464
Sortino Ratio Rank
CLNN Omega Ratio Rank: 6363
Omega Ratio Rank
CLNN Calmar Ratio Rank: 5656
Calmar Ratio Rank
CLNN Martin Ratio Rank: 5353
Martin Ratio Rank

RLYB
RLYB Risk / Return Rank: 9898
Overall Rank
RLYB Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
RLYB Sortino Ratio Rank: 9898
Sortino Ratio Rank
RLYB Omega Ratio Rank: 9696
Omega Ratio Rank
RLYB Calmar Ratio Rank: 9999
Calmar Ratio Rank
RLYB Martin Ratio Rank: 9999
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CLNN vs. RLYB - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Clene Inc. (CLNN) and Rallybio Corporation (RLYB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CLNNRLYBDifference
Sharpe ratioReturn per unit of total volatility

-4.61

Sortino ratioReturn per unit of downside risk

-3.90

Omega ratioGain probability vs. loss probability

1.18

1.62

-0.44

Calmar ratioReturn relative to maximum drawdown

0.69

18.95

-18.26

Martin ratioReturn relative to average drawdown

1.18

44.22

-43.03

CLNN vs. RLYB - Sharpe Ratio Comparison

The current CLNN Sharpe Ratio is 0.43, which is lower than the RLYB Sharpe Ratio of 5.04. The chart below compares the historical Sharpe Ratios of CLNN and RLYB, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CLNNRLYBDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.43

5.04

-4.61

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.50

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.42

-0.30

-0.11

Drawdowns

CLNN vs. RLYB - Drawdown Comparison

The maximum CLNN drawdown since its inception was -99.27%, roughly equal to the maximum RLYB drawdown of -98.93%. Use the drawdown chart below to compare losses from any high point for CLNN and RLYB.


Loading charts...

Drawdown Indicators


CLNNRLYBDifference

Max Drawdown

Largest peak-to-trough decline

-99.27%

-98.93%

-0.34%

Max Drawdown (1Y)

Largest decline over 1 year

-68.64%

-31.05%

-37.59%

Max Drawdown (3Y)

Largest decline over 3 years

-89.13%

-97.19%

+8.06%

Max Drawdown (5Y)

Largest decline over 5 years

-99.13%

Current Drawdown

Current decline from peak

-98.23%

-91.42%

-6.81%

Average Drawdown

Average peak-to-trough decline

-84.68%

-79.17%

-5.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

39.77%

13.28%

+26.49%

Volatility

CLNN vs. RLYB - Volatility Comparison

Clene Inc. (CLNN) has a higher volatility of 30.10% compared to Rallybio Corporation (RLYB) at 19.93%. This indicates that CLNN's price experiences larger fluctuations and is considered to be riskier than RLYB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CLNNRLYBDifference

Volatility (1M)

Calculated over the trailing 1-month period

30.10%

19.93%

+10.17%

Volatility (6M)

Calculated over the trailing 6-month period

75.50%

72.03%

+3.47%

Volatility (1Y)

Calculated over the trailing 1-year period

111.80%

116.79%

-4.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

103.31%

109.57%

-6.26%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

112.76%

109.57%

+3.19%

Dividends

CLNN vs. RLYB - Dividend Comparison

Neither CLNN nor RLYB has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CLNN vs. RLYB - Financials Comparison

This section allows you to compare key financial metrics between Clene Inc. and Rallybio Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00K100.00K150.00K200.00K250.00K300.00K20222023202420252026
15.00K
212.00K
(CLNN) Total Revenue
(RLYB) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CLNN and RLYB have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CLNN has higher volatility (30.10%) compared to RLYB (19.93%). In terms of maximum drawdown, CLNN dropped -99.27% vs RLYB's -98.93%.

RLYB currently has the higher Sharpe Ratio (5.04 vs 0.43), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CLNN and RLYB

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer